Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.43 CAD | +0.95% | -.--% | +2.06% |
May. 23 | Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director | CI |
May. 21 | Extendicare Price Target Raised to $8.50 at RBC | MT |
Sales 2024 * | 1.43B 1.05B | Sales 2025 * | 1.44B 1.06B | Capitalization | 620M 454M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.43 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 23,500 |
Yield 2024 * |
6.46% | Yield 2025 * |
10.9% | Free-Float | 86.08% |
Latest transcript on Extendicare Inc.
1 day | +0.95% | ||
1 month | +2.48% | ||
3 months | +9.91% | ||
6 months | +6.60% | ||
Current year | +2.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-03-11 | |
David Bacon
DFI | Director of Finance/CFO | - | 19-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Aladin Mawani
BRD | Director/Board Member | 72 | 17-11-30 |
Alvin Libin
BRD | Director/Board Member | - | 84-01-19 |
Director/Board Member | - | 95-02-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 11 M€ | -.--% | ||
0.04% | 1 M€ | -.--% | - | |
0.00% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7.43 | +0.41% | 161,014 |
24-05-30 | 7.4 | +0.54% | 87,798 |
24-05-29 | 7.36 | -0.67% | 79,468 |
24-05-28 | 7.41 | -1.72% | 118,703 |
24-05-27 | 7.54 | +1.48% | 34,719 |
Delayed Quote Toronto S.E., May 31, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.06% | 454M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-5.56% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+70.11% | 13.09B | |
+79.20% | 13.21B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- EXE Stock